|[June 19, 2014]
Vestiage Accelerates Retail Growth with Appointment of New National VP of Sales
NEWPORT BEACH, Calif. --(Business Wire)--
With a focus on expanding their retail presence, Vestiage™, Inc.
("VEST"), the healthy-aging Company, has appointed industry veteran
Laura Stall to the position of National VP of Sales. Laura brings a wide
range of sales experience to Vestiage, Inc., along with a proven track
record of sales success across a multitude of channels.
Prior to joining Vestiage, Laura held various high-level positions such
as Vice President Sales, Director of Consumer Marketing, Director of
Trade Marketing, and Chain Sales Manager with such Fortune 100 Companies
as PepsiCo, The Pillsbury Company, Aurora Foods, MillerCoors and
Twinings Teas of London.
"I am very pleased not only to have joined Vestiage earlier this year,
but am now looking forward to my new position and expanded
responsibility," said Stall. "The industry has been very responsive to
our REGIMEN™ brand and we are confident that we will be in expanded
retail distribution soon. I have personally made the sales calls at
major retailers such as Kroger and Select Nutrition as well as appointed
well respected brokers to major accounts for Vestiage. We are looking
forward to working with these selected broker partners to expand into
the Natural, Drug and Mass classes of business. We are positioned for
growth and I am exceedingly optimistic about the multiple benefits our
products offer the consumer."
As National VP of Sales, Laura's responsibilities include the sales and
marketing aspect within the grocery, natural and other retail channels
of the Company's natural, healthy-aging lines; REGIMEN for men and
Monterey Bay Nutraceuticals for women. In 2014 the Company started with
a small retail presence. By the end of the year, the Company expects to
have established a national retail presence with high quality retailers.
"I'm very pleased to have Laura Stall taking over total responsibility
for sales of our brands with her particular focus being on the expansion
of our footprint into national retailers," said Scott Kimball, CEO for
Vestiage, Inc. "Laura has great energy, drive and a super attitude. She
hit the ground running since joining the Company in February, and as a
result, Vestiage and REGIMEN now have a pipeline of national retailers
from whom we have received commitments. We expect to recognize the
initial purchase orders from these high quality retailers in the third
and fourth quarters of this year. These are 'blue chip' retailers who
provide strong credibility for the RegiMEN brand and are expected to
expand our retail presence quite significantly."
Vestiage™ (stock symbol "VEST")
is a publicly traded healthy aging company. The Company offers premium
branded science-based nutraceuticals to a premium consumer base through
multiple channels. The Company is a sales, marketing, and distribution
company specializing in bringing science-based products to the healthy
aging consumer. The Company utilizes key partners to integrate
production, fulfilment, customer service, advertising, sales, media,
marketing, distribution, new product development and acquisitions.
Vestiage is focused on the use of the best ingredients from the ocean
and earth, including cutting edge, patented, clinically proven
ingredients to produce highly potent, and elegantly formulated products.
Using potency that matches the clinical results, and novel ingredient
combinations, Vestiage™ creates and distributes nutraceuticals such as
RegiMEN for men (www.BuyRegimen.com)
and the multifunctional Monterey Bay Nutraceuticals line for women (www.MontereyBayNutra.com).
Vestiage™ brands address the top "in demand" healthy aging concerns of
men and women. Vestiage™ research is focused on extending the active
period of a human life covering both the cognitive and physical realms.
To learn more, visit the Company website, www.vestiageinc.com.
As with many fast-growing companies, our growth is dependent upon
adequate funding for inventory, media, general overhead, professional
fees, technology, salaries and other expenses related to the business.
We have been able to obtain this funding to date, however, should we be
unable in the future to obtain appropriate funding to pay our expenses
and media at current levels, our growth, and our financial stability,
may be negatively impacted.
This Press Release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995 with
respect to our financial condition, results of operations and business.
These forward looking statements can be identified by the use of terms
such as "believe," "expects," "plan," "intend," "may," "will," "should,"
"can," or "anticipates," or the negative thereof, or variations thereon,
or comparable terminology, or by discussions of strategy. These
statements involve known and unknown risks, uncertainties and other
factors that may cause industry trends or our actual results to be
materially different from any future results expressed or implied by
these statements. Important factors that may cause our results to differ
from these forward-looking statements include, but are not limited to:
(i) changes in or new government regulations or increased enforcement of
the same, (ii) unavailability of desirable acquisitions or inability to
complete them, (iii) increased costs, including from increased raw
material or energy prices, (iv) changes in general worldwide economic or
political conditions, (v) adverse publicity or negative consumer
perception regarding nutritional supplements, anti-aging or stem cell
facial care products or stem cell technology in general, (vi) issues
with obtaining raw materials of adequate quality or quantity, (vii)
litigation and claims, including product liability, intellectual
property and other types, (viii) disruptions from or following
acquisitions including the loss of customers, (ix) increased
competition, (x) slow or negative growth in the anti-aging or cosmetics,
beauty, or nutritional supplement industry or the healthy foods or
anti-aging channel, (xi) the loss of key personnel or the inability to
manage our operations efficiently, (xii) problems with information
management systems, manufacturing efficiencies and operations, (xiii)
insurance coverage issues, (xiv) the volatility of the stock market
generally and of our stock specifically, (xv) increases in the cost of
borrowings or unavailability of additional debt or equity capital, or
both, or fluctuations in foreign currencies, and (xvi) interruption of
business or negative impact on sales and earnings due to acts of God,
acts of war, terrorism, bio-terrorism, civil unrest and other factors
outside of our control.
[ Back To TMCnet.com's Homepage ]